| 1 | 22 10 2025 | Govt discusses challenges faced by exporters during import, export clearance of temperature sensitive consignments | Pharmabiz | India | 
				
			| 2 | 22 10 2025 | Govt should mandate PG cos to supply small quantities 'as required' by MSMEs to halt contamination: TN IDMA | Pharmabiz | India | 
				
			| 3 | 22 10 2025 | Health ministry to mandate tracking mechanism for vaccines, antimicrobials, cancer and N&P drugs | Pharmabiz | India | 
				
			| 4 | 22 10 2025 | Health ministry issues draft amendment to move preparations with higher alcoholic content under Schedule H1 | Pharmabiz | India | 
				
			| 5 | 22 10 2025 | ACG to invest $200 million in U.S. hard-shell capsule manufacturing | India Pharma Post | India | 
				
			| 6 | 22 10 2025 | CCI clears Torrent Pharma's proposal to buy stake in JB Chemicals | Health  world(Economic Times) | India | 
				
			| 7 | 22 10 2025 | Civica to market Biocon Biologics Insulin Glargine in US | Health  world(Economic Times) | India | 
				
			| 8 | 20 10 2025 | Pharmexcil seeks inputs from exporters for review of RoDTEP scheme | Pharmabiz | India | 
				
			| 9 | 20 10 2025 | Ayush and herbal products imports grew 60% in August | Pharmabiz | India | 
				
			| 10 | 20 10 2025 | DoP seeks EoI for manufacturing & supplying pharmaceutical products for Brazil | Pharmabiz | India | 
				
			| 11 | 20 10 2025 | Biocon Biologics and Civica expand US nsulin access | Pharmabiz | India | 
				
			| 12 | 20 10 2025 | Dr.Reddy's Labs gets CDSCO panel nod to manufacture , Market Semaglutide Injection. | Medical Dialogues | India | 
				
			| 13 | 20 10 2025 | Alembic Pharmaceuticals secures USFDA approval for Triamcinolone Acetonide Injectable Suspension | Express Pharma | India | 
				
			| 14 | 20 10 2025 | PCI asks institutions to complete onboarding AEBAS by end of December | Pharmabiz | India | 
				
			| 15 | 20 10 2025 | AICDF demands action against some companies in WB for illegal brand promotion & price manipulation | Pharmabiz | India | 
				
			| 16 | 19 10 2025 | Pharma Firm gets HC Relief in Rs.64 Lakhs NPPA over pricing row over DOLOCIDE-MR | Medical Dialogues | India | 
				
			| 17 | 19 10 2025 | Cupid achieves CE (EU IVDR) certification for pregnancy and syphilis test kits | India Pharma Post | India | 
				
			| 18 | 19 10 2025 | Gujarat Themis Biosyn doubles fermentation production capacity at Vapi | India Pharma Post | India | 
				
			| 19 | 18 10 2025 | Indian Pharma eyes Russian market: Firms explore localised production;target to build largest API hub | Times of India | India | 
				
			| 20 | 18 10 2025 | India refuses drugmakers request to extend deadline for plant upgradation. | Medical Dialogues | India |